Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 13/20 | 0.56 |
| ▸ | SLC5A1 | P13866 | 6/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23075233 | 0.84 | SLC5A2 (0.69) | SLC5A2SLC5A1 | |
| SCHEMBL21515201 | 0.84 | SLC5A2 (0.69) | SLC5A2SLC5A1 | |
| SCHEMBL15981949 | 0.82 | ACHE (0.43) | SLC5A2 | |
| SCHEMBL12844835 | 0.82 | SLC5A2 (0.55) | SLC5A2SLC5A1 | |
| SCHEMBL8224471 | 0.82 | SLC5A2 (0.55) | SLC5A2SLC5A1 | |
| SCHEMBL19886246 | 0.82 | TYR (0.71) | SLC5A2SLC5A1 | |
| SCHEMBL15820964 | 0.82 | SLC5A2 (0.51) | SLC5A2 | |
| SCHEMBL15820966 | 0.82 | SLC5A2 (0.51) | SLC5A2 | |
| SCHEMBL15982081 | 0.81 | ACHE (0.42) | SLC5A2 | |
| SCHEMBL27730414 | 0.80 | TYR (0.55) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101255178-A | C-glycoside and C-glycoside compound containing substituted aromatic rings as well as preparation and use thereofb | RADIATION MEDICAL INST PLA ACA (CN) | 2008-09-03 | — | — | CN | claimed |
| CN-101255178-A | C-glycoside and C-glycoside compound containing substituted aromatic rings as well as preparation and use thereofb | RADIATION MEDICAL INST PLA ACA (CN) | 2008-09-03 | — | — | CN | disclosed |